Paper Details

  1. Home
  2. Paper Details

Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccine.

Author: AmanteFiona, AndrewDean, BarberBridget E, BlanchAdam J, BoyleMichelle J, ChanJo-Anne, CowmanAlan F, CraigAlister, DixonMatthew W A, DuffyMichael F, EngwerdaChristian, ErikssonEmily M, EvansKrystal, GriffinPaul, HealerJulie, JenningsHelen, McCarthyJames S, OdedraAnand, PapenfussAnthony T, PeningtonJocelyn, SathePriyanka, SchofieldLouis, SekuloskiSilvana, StormJanet, TilleyLeann, TrenholmeKatharine R, WebsterRebecca, WoolleyStephen, de Labastida RiveraFabian

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study describes the development of a genetically attenuated malaria vaccine targeting the knob-associated histidine-rich protein (KAHRP), essential for parasite virulence. This vaccine, designed to be safe and immunogenic, is currently being tested in healthy volunteers for its safety, infectivity, and ability to induce an immune response.
Paper Details　
Original Abstract of the Article :
There is a clear need for novel approaches to malaria vaccine development. We aimed to develop a genetically attenuated blood-stage vaccine and test its safety, infectivity, and immunogenicity in healthy volunteers. Our approach was to target the gene encoding the knob-associated histidine-rich prot...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606250/

データ提供：米国国立医学図書館（NLM）

Safety, Infectivity, and Immunogenicity of a Genetically Attenuated Malaria Vaccine

The fight against malaria is a continuous battle, like a desert war against a relentless enemy. This study investigates the safety, infectivity, and immunogenicity of a genetically attenuated blood-stage malaria vaccine. Researchers focused on modifying the gene encoding the knob-associated histidine-rich protein (KAHRP), aiming to create a vaccine that safely generates an immune response against the parasite.

A Promising Approach to Malaria Vaccine Development

This study provides promising results for the development of a safe and effective genetically attenuated blood-stage malaria vaccine. The authors found that their vaccine was safe, non-infectious, and generated an immune response in volunteers. This research represents a significant step towards controlling malaria, a disease that continues to threaten millions around the world. Just as a desert oasis provides a respite from the harsh environment, this research offers hope for a future where malaria is no longer a threat.

Harnessing the Power of Genetics for Malaria Control

This research demonstrates the potential of genetic engineering to develop effective vaccines against infectious diseases. The authors' approach of attenuating the malaria parasite while preserving its immunogenicity is a testament to the power of modern science to address global health challenges. Just as a skilled desert engineer can adapt to the harsh environment, this research shows how scientific ingenuity can be used to combat disease.

Dr.Camel's Conclusion

This study offers a promising new approach to malaria vaccine development. The researchers' innovative use of genetic attenuation to create a safe and immunogenic vaccine is a significant step forward in the fight against this debilitating disease. This research holds the potential to transform the lives of millions who are vulnerable to malaria.
Date :
  1. Date Completed 2022-01-24
  2. Date Revised 2022-05-31
Further Info :

Pubmed ID

34802442

DOI: Digital Object Identifier

PMC8606250

Related Literature

Article Analysis
・Effects of artemether and lumefantrine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.